°øÀ¯Çϱâ
À¯¹æ »ý°ËÀÇ Ãֽбâ¹ý: Áø°ø º¸Á¶ À¯¹æ »ý°Ë
±¸¸ÅÈıâ 0°Ç
¤ýµµ¼­Á¤º¸ ÀúÀÚ : RENZO BRUN DEL RE
ÃâÆÇ»ç : °¡º»ÀÇÇÐ
2010³â 08¿ù 25ÀÏ Ãâ°£  |  ISBN : 8992006845  |  225ÂÊ  |  B5(182 x 257 mm)  |  1ÆÇ
¤ý±³º¸È¸¿ø ±³º¸¹®°í ID ¿¬°áÇϱâ
µµ¼­¸¦ ±¸ÀÔÇÏ½Ã¸é ±³º¸¹®°í¿Í ²É¸¶ÀÇ È¸¿øÇýÅÃÀ» ÇÔ²²
¹ÞÀ¸½Ç ¼ö ÀÖ½À´Ï´Ù.
¤ý²É¸¶°¡ 60,000¿ø 54,000¿ø 10%
¤ýÃß°¡ÇýÅà ²É 3¼ÛÀÌ
²É¼ÛÀÌÁö°© ¸¸µé±â>
²É¼ÛÀÌ Àû¸³À» À§Çؼ­ '²É¼ÛÀÌÁö°©'À» ¸¸µå¼Å¾ß ÇÕ´Ï´Ù.
¤ý¹è¼ÛÁö¿ª ±¹³»
¤ý¹è¼Ûºñ
Á¶°ÇºÎ¹«·á¹è¼Û
  • ÀÌ °¡°ÔÀÇ ¹«·á¹è¼Û »óǰÀ» ÇÔ²² ÁÖ¹®Çϰųª, ÃÑÁÖ¹®±Ý¾×ÀÌ 15,000¿ø ÀÌ»óÀÌ¸é ¹«·á¹è¼Û.
  • 15,000¿ø ¹Ì¸¸ÀÌ¸é ¹è¼Ûºñ 2,500¿ø °í°´ºÎ´ã
  • µµ¼­»ê°£/Á¦ÁÖµµ´Â Ãß°¡¿îÀÓºñ ºÎ°úµÉ ¼ö ÀÖÀ½
1ÀÏ À̳» Ãâ°í
¤ý¼ö·®
ÃÑ ÇÕ°è±Ý¾×  ¿ø
Âò
¼±¹°
Àå¹Ù±¸´Ï ´ã±â
¹Ù·Î ±¸¸ÅÇϱâ

Àå¹Ù±¸´Ï¿¡ ´ã¾Ò½À´Ï´Ù. Àå¹Ù±¸´Ï¸¦ È®ÀÎ ÇϽðڽÀ´Ï±î?

¼îÇΰè¼ÓÇϱâ
Àå¹Ù±¸´Ïº¸±â
¤ýÀÌ °¡°ÔÀÇ ´Ù¸¥ »óǰ ¸ðµç»óǰº¸±â+
18,000¿ø
16,200¿ø 10%¡é
16,800¿ø
15,120¿ø 10%¡é
25,000¿ø
22,500¿ø 10%¡é
17,000¿ø
15,300¿ø 10%¡é
²ÞÀ» ÇÇ¿ì´Â ¼¼»ó, ÀÎÅÍ³Ý ±³º¸¹®°íÀÔ´Ï´Ù.
²ÞÀ» ÇÇ¿ì´Â ¼¼»ó, ÀÎÅÍ³Ý ±³º¸¹®°íÀÔ´Ï´Ù.
°¡°ÔÁÖÀÎ : ±³º¸¹®°í
ÀüÈ­ ¹× ÅùèÁ¤º¸
ÀüÈ­ ¹× ÅùèÁ¤º¸
»óǰ ¾È³» ¹× ȯºÒ, ±³È¯, ¹è¼Û¹®ÀÇ
- °¡°Ô ÀüÈ­¹øÈ£ : 1544-1900
- ÀüÈ­¹®ÀÇ ½Ã°£ : ¿ÀÀü 9½ÃºÎÅÍ ¿ÀÈÄ 6½Ã±îÁö
(¸ÅÁÖ ¿ù¿äÀÏ, È­¿äÀÏ, ¼ö¿äÀÏ, ¸ñ¿äÀÏ, ±Ý¿äÀÏ, °øÈÞÀÏ Á¦¿Ü)
- °¡°Ô À̸ÞÀÏ : ink@kyobobook.co.kr
- ÀÌ¿ë Åùèȸ»ç : CJ´ëÇÑÅë¿î
ÆÇ¸Å°¡°ÔÁ¤º¸
- »ç¾÷ÀÚ¸í : (ÁÖ)±³º¸¹®°í
- »ç¾÷ÀÚµî·Ï¹øÈ£ : 102-81-11670
- Åë½ÅÆÇ¸Å¾÷½Å°í : 01-0653
- Çö±Ý¿µ¼öÁõ : ¹ß±Þ°¡´É
ÀüÈ­ÁÖ¹® ¹× °áÁ¦¹®ÀÇ
- ²ÉÇÇ´Â ¾ÆÄ§¸¶À» : 1644-8422
°¡°Ô¿Í Á÷°Å·¡¸¦ ÇÏ½Ã¸é ²É¼ÛÀÌ Àû¸³ ¹× °¢Á¾ ÇýÅÿ¡¼­
Á¦¿ÜµÇ°í, ¸¸ÀÏÀÇ ¹®Á¦°¡ ¹ß»ýÇÏ´Â °æ¿ì¿¡µµ ²É¸¶ÀÇ
µµ¿òÀ» ¹ÞÀ¸½Ç ¼ö ¾ø½À´Ï´Ù. °¡°ÔÀÇ ºÎ´çÇÑ ¿ä±¸,
ºÒ°øÁ¤ ÇàÀ§ µî¿¡ ´ëÇØ¼­µµ ²É¸¶·Î Á÷Á¢ ÀüÈ­ÁÖ¼¼¿ä.
 À̾߱â²É¹ç
µî·ÏµÈ À̾߱Ⱑ ¾ø½À´Ï´Ù.
»ó¼¼Á¤º¸ ±¸¸ÅÈıâ (0) »óǰ Q&A (0) ¹è¼Û/±³È¯/ȯºÒ ¾È³»

Ã¥¼Ò°³

À¯¹æ »ý°ËÀÇ Ãֽбâ¹ýÀ» ´Ù¾çÇÑ »çÁø°ú °ü·Ã ÀÚ·á·Î Àϸñ¿ä¿¬ÇÏ°Ô Á¤¸®ÇÑ Ã¥.

¸ñÂ÷

1 Senologic ¼Ò°ßÀÇ ¹®¼­È­¿Í »ó°ü¼º Documentation and Correlation of Senologic Findings Renzo Brun del Re 1.1 µµÀÔ Introduction 1.2 Senometry 1.2.1 Áغñ¹° Material 1.3 ÀÓ»ó ¼Ò°ß Ç¥½ÃÇϱâ Mapping Clinical Findings 1.4 2 cm º¸´Ù ÀÛÀº À¯¹æ º´º¯ À§Ä¡ Ç¥½ÃÇϱâ Mapping Mammographic Lesions Smaller than 2 cm 1.4.1 À¯¹æÃÔ¿µ»ó¿¡ ³ªÅ¸³­ º´º¯¿¡ ´ëÇÑ À§Ä¡ Ç¥½Ã Mapping the Lesion on the Mammogram 1.4.2 À¯¹æÃÔ¿µ»óÀÇ ¼öÄ¡¸¦ À¯¹æ À§·Î ¿Å±â±â Transferring the Mammographic Dimensions onto the Breast 1.5 ¼ö¼ú ÁßÀÇ senometry¸¦ ÀÌ¿ëÇÑ Ä§ À§Ä¡ °áÁ¤¹ý Intraoperative Senometric Needle Localization 15 1.6 2 cm º¸´Ù Å« À¯¹æÃÔ¿µ»óÀÇ À¯¹æº´º¯ÀÇ µµ½ÄÈ­ Mapping Mammographic Lesions Larger than 2 cm 1.6.1 À¯¹æÃÔ¿µ»ó ³ªÅ¸³­ º´º¯ À§Ä¡ÆÄ¾ÇÇϱâ Mapping the Lesion on the Mammogram 1.6.2 ÃøÁ¤µÈ ¼öÄ¡¸¦ À¯¹æ À§·Î ¿Å±â±â Transferring Dimensions onto the Breast 1.7 ÃÊÀ½ÆÄ»ó È®ÀÎµÈ ºñ ÃËÁö¼º º´º¯ Nonpalpable Lesion Detected by Ultrasound 1.8 SenometryÀÇ ÀÌÁ¡ Advantages of Senometry References 2 ´ë±¸°æ Áø°øº¸Á¶ À¯¹æ »ý°Ë°ú ÀýÁ¦ »ý°ËÀÇ ºñ±³ Comparison of Large-Core Vacuum-Assisted Breast Biopsy and Excision Systems Robin Wilson and Sanjay Kavia 2.1 ¼­·Ð Introduction 2.2 ´ë±¸°æ Á᫐ »ý°Ë ½Ã½ºÅÛ : °³°ü Large-Core Biopsy Systems: Overview 2.2.1 ´ÜÀÏ ´ë±¸°æ-Á᫐ »ý°Ë ½Ã½ºÅÛ Single Large-Core Biopsy System 2.2.2 Áø°ø-º¸Á¶ À¯¹æ »ý°Ë ½Ã½ºÅÛ Vacuum-Assisted Mammotomy Systems 2.3 ÀûÀÀ°ú ÇѰè Indications and Limitations 2.3.1 ÇѰèÁ¡ Limitations 2.3.2 Áø´ÜÀû »ý°Ë Diagnostic Biopsy 2.3.3 Ä¡·áÀû ÀýÁ¦¼ú Therapeutic Excision 2.3.4 À̹ÌÁö À¯µµÇÏ »ý°Ë ±â¼ú Image-Guided Biopsy Technique 2.4 °á·Ð Conclusions References 3 ÇÚµå Çïµå ¸¾¸ðÅèÀ» ÀÌ¿ëÇÑ ÃÊÀ½ÆÄ À¯µµÇÏ Áø°ø º¸Á¶ À¯¹æ »ý°Ë¼ú Sonographically Guided Vacuum-Assisted Breast Biopsy Using Handheld Mammotome Luc Steyaert, Filip Van Kerkhove, and Jan W. Casselman 3.1 ¼­·Ð Introduction 3.2 Àåºñ Equipment 3.3 ±â¼ú Technique 3.4 ÀûÀÀÁõ Indications 3.4.1 ¾ç¼º ÀÇ½É È¤Àº ºÒÈ®½ÇÇÑ °áÀý¼º º´º¯ Probably Benign or Indeterminate Nodular Lesions 3.4.2 ¸Å¿ì ÀÛÀº Å©±âÀÇ ÀÇ½É º´º¯µé Very Small Suspicious Lesions 3.4.3 ±¹¼Ò °¨¼è ºÎºÐ Areas of Localized Attenuation 3.4.4 µ¶¸³µÈ, º¹ÇÕ ¼¶À¯ ³¶Á¾¼º ºÎºÐµé Isolated, Complex Fibrocystic Areas 3.4.5 À¯µÎÁ¾ Papillomas 3.4.6 ±ºÁý¼º ¹Ì¼¼¼®È¸È­ Clusters of Microcalcifications 3.4.7 ¾î·Á¿î À§Ä¡¿¡ ÀÖ´Â º´º¯µé Lesions in Difficult Locations 3.4.8 ÀÌÀü »ý°Ë ¶Ç´Â FNAC »ó ºñ °áÁ¤ÀûÀÎ ¸Å¿ì ´Ü´ÜÇÑ º´º¯µé Very Hard Lesions with Inconclusive Previous Biopsy or FNAC 3.4.9 ºÒÃæºÐÇÑ FNAC ¶Ç´Â ¹Ì¼¼»ý°Ë °á°ú Inadequate FNAC or Microbiopsy Results 3.4.10 ¾ç¼º º´º¯ÀÇ Á¦°Å Removal of Benign Lesions 3.4.11 ³íÀÇµÈ ÀûÀÀÁõµé : ¹æ»ç»ó ¹ÝÈç, Å« ³¶Á¾ ³» º´º¯µé Indications Discussed: Radial Scar, Large Intracystic Lesions 3.4.12 ´Ù¸¥ ÀûÀÀÁõµé Other Indications 3.5 Á᫐ °Ëü ó¸®Çϱâ Processing the Cores 3.6 ŽħÀÇ ±½±â Needle Size 3.7 Ŭ¸³ À§Ä¡½Ã۱â Clip Placement 3.8 ÃÊÀ½ÆÄ À¯µµ Vs À¯¹æÃÔ¿µ»ó À¯µµ US Versus Mammographic Guidance 3.9 °á°ú Results References 4 Vacora »ý°Ë ½Ã½ºÅÛ TheVacora Biopsy System R. Schulz-Wendtland 4.1 µµÀÔ Introduction 4.2 ±â¼ú Technique 4.3 ÀûÀÀÁõ°ú ±Ý±â»çÇ× Indications and Contraindications 4.3.1 ÃÊÀ½ÆÄ À¯µµÇÏ °æÇÇÀû Áø°ø »ý°Ë US-Guided Transcutaneous Vacuum Biopsy 4.3.2 Á¤À§Àû Áø°ø »ý°Ë Stereotactic Vacuum Biopsy 4.3.3 MRI À¯µµÇÏ Áø°ø »ý°Ë MRI-Guided Vacuum Biopsy 4.4 ºÎÀÛ¿ë Side Effects 4.5 °á°ú Results 4.6 ÇѰè Limitations 4.7 ½Ç¿ëÀûÀÎ ÈùÆ® Practical Hints References 5 Á¤À§Àû À¯¹æ »ý°Ë Available Stereotactic Systems for Breast Biopsy Ossi R. K?hli 5.1 µµÀÔ Introduction 5.1.1 ¾þµå¸° ÀÚ¼¼ ¹æ½Ä Prone Position Techniques 5.1.2 ¼öÁ÷ ½Ã½ºÅÛ Upright Systems 5.2 ½Ã½ºÅÛÀÇ ºñ¿ë Cost of the Systems 5.3 ½Ã¼úÀÇ ºñ¿ë Cost of the Procedures References 6 MRI À¯µµÇÏ ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë MRI-Guided Minimally Invasive Breast Procedures Harald Marcel Bonel 6.1 µµÀÔ : MR ¸¾¸ð±×·¡ÇÇÀÇ ¿ªÇÒ Introduction: Role of MR Mammography 6.1.1 ÀûÀÀÁõ Indications 6.1.2 ±â¼ú°ú ½ÇÁ¦ÀûÀÎ ÆÁ Technique and Practical Tips 6.1.3 ÇѰè Limitations 6.2 °á·Ð Conclusion References 7 À¯°ü³» Á¾¾ç¿¡ ´ëÇÑ À¯°ü³»½Ã°æ Ductoscopy of Intraductal Neoplasia of the Breast Michael H?erbein, Matthias Raubach, Y.Y. Dai, and Peter M. Schlag 7.1 µµÀÔ Introduction 7.2 À¯°ü³» À¯¹æ ¼¼Æ÷¸¦ äÃëÇϱâ À§ÇÑ ¹æ¹ý Methods for Sampling Intraductal Breast Cells 7.2.1 À¯°ü³»½Ã°æ ±â¼ú Technique of Ductoscopy 7.2.2 À¯°ü³»½Ã°æ »ý°Ë Ductoscopic Biopsy 7.2.3 À¯µÎ ºÐºñ¹°ÀÌ ÀÖ´Â ¿©¼º¿¡¼­ÀÇ À¯°ü³»½Ã°æ Ductoscopy in Women with Nipple Discharge 7.2.4 À¯¹æ¾Ï¿¡¼­ÀÇ À¯°ü³»½Ã°æ Ductoscopy in Breast Cancer 7.3 ¿ä¾à Summary References 8 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë Á¶Á÷ÀÇ º´¸® Pathology of Breast Tissue Obtained in Minimally Invasive Biopsy Procedures Gad Singer and Sylvia Stadlmann 8.1 µµÀÔ Introduction 8.2 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë Á¶Á÷ÀÇ º´¸® Pathology of Breast Disease in Minimally Invasive Biopsies 8.3 ¾ç¼º »óÇÇÁúȯ Benign Epithelial Lesions 8.3.1 °üÁÖÀ§ À¯¹æ¿° Periductal Mastitis 8.3.2 ¼¶À¯³¶Á¾¼º º¯È­ Fibrocystic Change 8.3.3 °æÈ­¼º ¼±Áõ Sclerosing Adenosis 8.3.4 ¿øÁÖ¼¼Æ÷ º´º¯ Columnar Cell Lesions 8.3.5 º¸ÅëÀÇ »óÇÇ Áõ½Ä Usual-Type Epithelial Hyperplasia 8.3.6 ¼Ò¿±¼º Á¾¾ç Lobular Neoplasia 8.4 ¼¶À¯»óÇǼº º´º¯ Fibroepithelial Lesions 8.4.1 ¼¶À¯¼±Á¾ Fibroadenoma 8.4.2 ¿±»ó Á¾¾ç Phyllodes Tumor 8.4.3 ¾ç¼º À¯µÎ»ó º´º¯ Benign Papillary Lesions 8.5 ºñħÀ±¼º ¾Ï Malignant Noninvasive Lesions 8.6 ħÀ±¼º ¾Ï Invasive Carcinoma 8.7 À¯¹æ¾ÏÀÇ µî±Þ °áÁ¤ Grading of Breast Carcinoma 8.8 ÃÖ¼Ò Ä§½ÀÀû »ý°Ë¿¡¼­ÀÇ ¿¹Ãø ÀÎÀÚ Predictive Factors in MIBS References 9 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°ËÀÇ ÇѰè Limitations of Minimally Invasive Breast Biopsy Mathias K. Fehr 9.1 ±â¼úÀûÀÎ ½ÇÆÐ Technical Failures 9.2 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°Ë¿¡¼­ À¯¹æ º´¸®ÀÇ °ú¼ÒÆò°¡ Underestimation of Breast Pathology on Minimally Invasive Breast Biopsy Specimens References 10 À¯¹æ ¿µ»óÀÇ ¹ßÀü: µô·¹¸¶ ȤÀº Áøº¸? Advances in Breast Imaging: A Dilemma or Progress? Daniel Fl?y, Michael W. Fuchsjaeger, Christian F. Weisman, and Thomas H. Helbich 10.1 µµÀÔ Introduction 10.2 ÃÊÀ½ÆÄ Ultrasound 10.2.1 ´Ù¸é Ç¥½Ã ¸ðµå Multiplanar Display Mode 10.2.2 ÇÔ¿ä ¸ðµå ¿µ»ó Niche Mode View 10.2.3 Ç¥¸é ¸ðµå Surface Mode 10.2.4 Åõ¸í ¸ðµå Transparency Mode 10.2.5 Á¤Àû 3Â÷¿ø ¿ëÀû ´ëÁ¶¿µ»ó Static 3D Volume Contrast Imaging 10.2.6 4Â÷¿ø ¿ëÀû ´ëÁ¶µµ¿µ»ó 4D Volume Contrast Imaging 10.2.7 ¿ªÀü ¸ðµå Inversion Mode 10.2.8 ¿ëÀû °è»ê Volume Calculation 10.2.9 ´ÜÃþ ÃÊÀ½ÆÄ ¿µ»ó Tomographic Ultrasound Imaging 10.2.10 À¯¸®Ã¼ ·»´õ¸µ Glass Body Rendering 10.2.11 °­È­ µµÇ÷¯, »öä µµÇ÷¯, ±×¸®°í °í¼±¸íµµ È帧 Power Doppler, Color Doppler, and High-Definition Flow 10.2.12 ¿¬ÀåµÈ ½Ã¾ß ±â·Ï Extended View Documentation 10.2.13 °á·Ð Conclusion 10.3 Àڱ⠰ø¸í ¿µ»ó Magnetic Resonance Imaging (MRI) 10.3.1 1.5-Å×½½¶ó ½Ã½ºÅÛ°ú Gadopentate 1.5-Tesla Systems and Gadopentetate 10.3.2 3.0-Å×½½¶ó ½Ã½ºÅÛ 3.0-Tesla Systems 10.3.3 °íºÐÀÚ Á¶¿µÁ¦ Macromolecular Contrast Agents 10.3.4 Á¾¾çƯÀÌ Á¶¿µÁ¦ Tumor-Specific Contrast Agents 10.3.5 ±â´ÉÀû À¯¹æ ¿µ»ó ±â¹ý (ºÐ±¤¹ý, È®»ê°­Á¶¿µ»ó) Functional Breast Imaging Techniques (Spectroscopy, Diffusion-Weighted Imaging) 10.4 ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ Positron Emission Tomography 10.4.1 ¼¼Æ÷ Áõ½Ä°ú ¼¼Æ÷ÀÚ¸ê»çÀÇ ¿µ»ó Imaging of Cellular Proliferation andApoptosis 10.4.2 ¼ö¿ëü ¿µ»ó Receptor Imaging 10.5 ±¤ÇÐ ¿µ»ó Optical Imaging 10.5.1 Çì¸ð±Û·Îºó ¿µ»ó Imaging of Hemoglobin 10.5.2 CTLM ÀåÄ¡ CTLM Device 10.5.3 ¿ÜÀμº Á¶¿µÁ¦ÀÇ ±¤ÇÐ ¿µ»ó Optical Imaging of Extrinsic Contrast Agents 10.6 Electrical Impedance Scanning 10.6.1 Ç¥Àû EIS¿Í TransScan TS2000 Targeted EIS with TransScanTS2000 10.6.2 T-Scan 2000ED¿Í Screening EIS 10.7 °á·Ð Conclusion References 11 ºñ¿ë-È¿°ú ºÐ¼® Cost-Benefit Analyses Renzo Brun del Re and Regula E. Burki 11.1 µµÀÔ Introduction 11.2 À¯¹æÃÔ¿µ¼úÀÇ ºóµµ Frequency of Mammography 11.3 ¼Òȯ·ü Recall Rate 11.3.1 ¼±º° °Ë»ç¿¡¼­ÀÇ ¼ÒȯÀ² Recall Rate in Screening Programs 11.3.2 ¼±º° ÇÁ·Î±×·¥ ¿ÜÀÇ ¼ÒȯÀ² Recall Rate Outside of Screening Programs 11.4 Ãß°¡ °Ë»çÀÇ ºÐÆ÷ Distribution of Further Investigations 11.4.1 ¿Ü°úÀû Àý°³ »ý°Ë Open (Surgical) Biopsy 11.4.2 Àý°³ »ý°ËÀÇ ´ëü Substitution of Open Biopsies 11.4.3 ´Ù¸¥ Áø´ÜÀû ±â¹ýÀÇ ´ëü Substitution of Other Diagnostic Procedures 11.5 °æÇâ°ú ½Ã³ª¸®¿À Trends and Scenarios 11.6 ºñ¿ëÀÇ ºñ±³ Comparison of Costs 11.6.1 ºñ¿ë°ú Àý¾à Costs and Savings 11.7 ÀÇ»ç °áÁ¤ÀÚ´Â ¹Ù²î¾ú´Ù Decision Makers Have Changed 11.8 °á·Ð Conclusions References 12 ÃÖ±Ù µ¥ÀÌÅÍÀÇ Ã¼°èÀû °ËÅä¿Í ¸ÞŸºÐ¼® Systematic Review and Meta-analysis of Recent Data Renzo Brun del Re and Regula E. 12.1 ÃÖ¼Ò Ä§½ÀÀû À¯¹æ »ý°ËÀÇ ÀÓ»óÀû ÀûÀý¼º¿¡ ´ëÇÑ Áõ°Å Evidence for the Clinical Relevance of Minimally Invasive Breast Biopsy 12.1.1 °í¹®ÇåÀÇ Ã¼°èÀû °ËÅä Older Systematic Reviews 12.2 ¹®Çå Á¶»ç ¹æ¹ý Literature Search Methods 12.2.1 ¼öÇà¿¡ ´ëÇÑ Áõ°Å Evidence on Performance 12.2.2 À§Ç輺°ú ¾ÈÁ¤¼º¿¡ ´ëÇÑ ±Ù°Å Evidence on Risks and Safety 12.2.3 µ¥ÀÌÅÍÀÇ ¹ßÇ¥¿Í ºÐ¼® Presentation and Analysis of the Data 12.3 µ¥ÀÌÅÍÀÇ ¹ßÇ¥¿Í ºÐ¼® Presentation and Analysis of the Data 12.3.1 »ç¿ëµÈ Áõ°Å Evidence Used 12.3.2 °á°ú Results 12.4 MIBBÀÇ ¾ÈÁ¤¼º Safety of MIBB 12.4.1 Àý´ëÇ¥ÁØÀ¸·Î¼­ÀÇ Àý°³»ý°Ë Open Biopsy as Gold Standard 12.4.2 14-G Á᫐ »ý°Ë°ú 11-G Áø°ø º¸Á¶ »ý°Ë 14-G Core Biopsies and 11 #NAME? Vacuum-Assisted Biopsies 12.4.3 MIBBÀÇ ¾ÈÁ¤¼º¿¡ ´ëÇÑ °á·Ð Conclusions on the Safety of MIBB 12.5 »îÀÇ Áú Quality of Life (HRQoL) 12.6 ¹ßÇ¥µÈ MIBB µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¿ä¾à°ú Åä·Ð Summary and Discussion of the MIBB Data Presented 12.7 °á·Ð Conclusions References
±¸¸ÅÈı⠱¸¸Å¸¸Á·µµ
ÀÌ »óǰ¿¡ ´ëÇÑ ±¸¸ÅÈıâ´Â ±¸¸ÅÇϽŠºÐ¿¡ ÇÑÇØ 'ÁÖ¹®/¹è¼ÛÁ¶È¸'¿¡¼­ ÀÛ¼ºÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
ÀÛ¼ºµÈ ±¸¸ÅÈıⰡ ¾ø½À´Ï´Ù.
    »óǰQ&A
    »óǰ¿¡ °üÇÑ ±Ã±ÝÇϽŠ»çÇ×À» ¹°¾îº¸¼¼¿ä!
    ±Û¾²±â
    ±Û¾²±â
      ¹è¼Û/±³È¯/ȯºÒ ¾È³»
      ¹è¼Û¾È³»
      - ÁÖ¹®±Ý¾×ÀÌ 15,000¿ø ÀÌ»óÀÎ °æ¿ì ¹«·á¹è¼Û, 15,000 ¹Ì¸¸ÀÎ °æ¿ì ¹è¼Ûºñ 2,500¿øÀÌ ºÎ°úµË´Ï´Ù. (´Ü, ¹«·á¹è¼Û »óǰÀÇ °æ¿ì Á¦¿Ü)
      - ÁÖ¹® ÈÄ ¹è¼ÛÁö¿ª¿¡ µû¶ó ±¹³» ÀϹÝÁö¿ªÀº ±Ù¹«ÀÏ(¿ù-±Ý) ±âÁØ 1Àϳ» Ãâ°íµÊÀ» ¿øÄ¢À¸·Î Çϳª, ±â»ó»óȲ µîÀÇ ÀÌÀ¯·Î Áö¿¬µÉ ¼öµµ ÀÖ½À´Ï´Ù. (´Ü, ÀÏ¿äÀÏ ¹× °øÈÞÀÏ¿¡´Â ¹è¼ÛµÇÁö ¾Ê½À´Ï´Ù.)
      - µµ¼­ »ê°£ Áö¿ª ¹× Á¦ÁÖµµÀÇ °æ¿ì´Â Ç×°ø/µµ¼± Ãß°¡¿îÀÓÀÌ ºÎ°úµÉ ¼ö ÀÖ½À´Ï´Ù.
      - ÇØ¿ÜÁö¿ªÀ¸·Î´Â ¹è¼ÛµÇÁö ¾Ê½À´Ï´Ù.
      ±³È¯/ȯºÒ ¾È³»
      - »óǰÀÇ Æ¯¼º¿¡ µû¸¥ ±¸Ã¼ÀûÀÎ ±³È¯ ¹× ȯºÒ±âÁØÀº °¢ »óǰÀÇ '»ó¼¼Á¤º¸'¸¦ È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
      - ±³È¯ ¹× ȯºÒ½ÅûÀº °¡°Ô ¿¬¶ôó·Î ÀüÈ­ ¶Ç´Â À̸ÞÀÏ·Î ¿¬¶ôÁֽøé ÃÖ¼±À» ´ÙÇØ ½Å¼ÓÈ÷ ó¸®ÇØ µå¸®°Ú½À´Ï´Ù.

      ±³È¯ ¹× ȯºÒ °¡´É »óǰ¿¡
      ¹®Á¦°¡ ÀÖÀ» °æ¿ì
      1) »óǰÀÌ Ç¥½Ã/±¤°íµÈ ³»¿ë°ú ´Ù¸£°Å³ª ºÒ·®(ºÎÆÐ, º¯Áú, ÆÄ¼Õ, Ç¥±â¿À·ù, À̹°È¥ÀÔ, Áß·®¹Ì´Þ)ÀÌ ¹ß»ýÇÑ °æ¿ì
      - ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ : ¼ö·ÉÀÏ ´ÙÀ½³¯±îÁö ½Åû
      - ±âŸ »óǰ : ¼ö·ÉÀϷκÎÅÍ 30ÀÏ À̳», ±× »ç½ÇÀ» ¾È ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏ À̳» ½Åû
      2) ±³È¯ ¹× ȯºÒ½Åû ½Ã ÆÇ¸ÅÀÚ´Â »óǰÀÇ »óŸ¦ È®ÀÎÇÒ ¼ö ÀÖ´Â »çÁøÀ» ¿äûÇÒ ¼ö ÀÖÀ¸¸ç »óǰÀÇ ¹®Á¦ Á¤µµ¿¡ µû¶ó Àç¹è¼Û, ÀϺÎȯºÒ, ÀüüȯºÒÀÌ ÁøÇàµË´Ï´Ù. ¹Ýǰ¿¡ µû¸¥ ºñ¿ëÀº ÆÇ¸ÅÀÚ ºÎ´ãÀ̸ç ȯºÒÀº ¹ÝǰµµÂøÀϷκÎÅÍ ¿µ¾÷ÀÏ ±âÁØ 3ÀÏ À̳»¿¡ ¿Ï·áµË´Ï´Ù.
      ´Ü¼øº¯½É ¹×
      ÁÖ¹®Âø¿ÀÀÇ °æ¿ì
      1) ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ
      ÀçÆÇ¸Å°¡ ¾î·Á¿î »óǰÀÇ Æ¯¼º»ó, ±³È¯ ¹× ȯºÒÀÌ ¾î·Æ½À´Ï´Ù.
      2) È­Àåǰ
      ÇǺΠƮ·¯ºí ¹ß»ý ½Ã Àü¹®ÀÇ Áø´Ü¼­ ¹× ¼Ò°ß¼­¸¦ Á¦ÃâÇϽøé ȯºÒ °¡´ÉÇÕ´Ï´Ù. ÀÌ °æ¿ì Á¦¹Ýºñ¿ëÀº ¼ÒºñÀÚ ºÎ´ãÀ̸ç, ¹è¼Ûºñ´Â ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù. ÇØ´ç È­Àåǰ°ú ÇǺΠƮ·¯ºí°úÀÇ »ó´çÇÑ Àΰú°ü°è°¡ ÀÎÁ¤µÇ´Â °æ¿ì ¶Ç´Â Áúȯġ·á ¸ñÀûÀÇ °æ¿ì¿¡´Â Áø´Ü¼­ ¹ß±Þºñ¿ëÀ» ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù.
      3) ±âŸ »óǰ
      ¼ö·ÉÀϷκÎÅÍ 7ÀÏ À̳» ½Åû, ¿Õº¹¹è¼Ûºñ´Â ¼ÒºñÀÚ ºÎ´ã
      4) ¸ð´ÏÅÍ ÇØ»óµµÀÇ Â÷ÀÌ·Î »ö»óÀ̳ª À̹ÌÁö°¡ ´Ù¸¥ °æ¿ì ´Ü¼øº¯½É¿¡ ÀÇÇÑ ±³È¯ ¹× ȯºÒÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
      ±³È¯ ¹× ȯºÒ ºÒ°¡ 1) ½Åû±âÇÑÀÌ Áö³­ °æ¿ì
      2) ¼ÒºñÀÚÀÇ °ú½Ç·Î ÀÎÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ Àüü ¶Ç´Â ÀϺΰ¡ ¾ø¾îÁö°Å³ª ÈѼÕ, ¿À¿°µÇ¾úÀ» °æ¿ì
      3) °³ºÀÇÏ¿© ÀÌ¹Ì ¼·ÃëÇÏ¿´°Å³ª »ç¿ë(Âø¿ë ¹× ¼³Ä¡ Æ÷ÇÔ)ÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ °¡Ä¡°¡ ¼Õ»óµÈ °æ¿ì
      4) ½Ã°£ÀÌ °æ°úÇÏ¿© »óǰÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
      5) »ó¼¼Á¤º¸ ¶Ç´Â »ç¿ë¼³¸í¼­¿¡ ¾È³»µÈ ÁÖÀÇ»çÇ× ¹× º¸°ü¹æ¹ýÀ» ÁöŰÁö ¾ÊÀº °æ¿ì
      6) »çÀü¿¹¾à ¶Ç´Â ÁÖ¹®Á¦ÀÛÀ¸·Î ÅëÇØ ¼ÒºñÀÚÀÇ ÁÖ¹®¿¡ µû¶ó °³º°ÀûÀ¸·Î »ý»êµÇ´Â »óǰÀÌ ÀÌ¹Ì Á¦ÀÛÁøÇàµÈ °æ¿ì
      7) º¹Á¦°¡ °¡´ÉÇÑ »óǰ µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
      8) ¸À, Çâ, »ö µî ´Ü¼ø ±âÈ£Â÷ÀÌ¿¡ ÀÇÇÑ °æ¿ì